Author: GlobeNewswire

New Director Brings Extensive Experience to Poise the Company for GrowthMALVERN, Pa., Dec. 29, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:…

Potential to become the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal…

Potential to become the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal…

PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) TO INITIATE THE CONFIRMATORY PHASE…

Attained U.S. Food and Drug Administration (FDA) Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 for…

NEWTON, Mass., Dec. 29, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,…

Four new executives from the life science industry each bring over twenty years of experience in the development, approval and…

BOSTON, Dec. 29, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA Oncology Company™ committed to more effectively…

MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) — Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a…

Tel Aviv, Israel / Vancouver, Canada, Dec. 29, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY)…